Congenital Hyperinsulinism
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
A rare case of congenital hyperinsulinism (CHI) due to dual genetic aetiology involving HNF4A and ABCC8.
|
30730840 |
2019 |
Congenital Hyperinsulinism
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Nevertheless, the HNF4A gene testing may be considered in selected CHI cases with glycogenosis-like phenotype prior WES analysis.
|
28242437 |
2017 |
Congenital Hyperinsulinism
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Congenital hyperinsulinism can also be associated with mutations in the HNF4A gene.
|
27552834 |
2016 |
Congenital Hyperinsulinism
|
0.200 |
Biomarker
|
disease |
BEFREE |
Two patients with HNF4A-related congenital hyperinsulinism and renal tubular dysfunction: A clinical variation which includes transient hepatic dysfunction.
|
25819479 |
2015 |
Congenital Hyperinsulinism
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
We report six patients heterozygous for the p.R76W HNF4A mutation who have Fanconi syndrome and nephrocalcinosis in addition to neonatal hyperinsulinism and macrosomia.
|
24285859 |
2014 |
Congenital Hyperinsulinism
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Glutamate dehydrogenase-CHI is the second most common cause of CHI, while HNF4A and GCK are rare types of CHI in Chinese patients.
|
25008049 |
2014 |
Congenital Hyperinsulinism
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
In this case series, we report three children with HNF4A mutations (two de novo) and diazoxide-responsive congenital hyperinsulinism, highlighting the potential for ongoing diazoxide requirement and the importance of screening for these mutations even in the absence of family history.
|
23796040 |
2014 |
Congenital Hyperinsulinism
|
0.200 |
Biomarker
|
disease |
BEFREE |
The HNF4A MODY phenotype has been expanded by the reports of macrosomia in ∼50% of babies, and more rarely, neonatal hyperinsulinemic hypoglycemia.
|
23348805 |
2013 |
Congenital Hyperinsulinism
|
0.200 |
Biomarker
|
disease |
BEFREE |
Mutations in GLUD1, HADH, GCK and HNF4A genes were sought in patients with diazoxide-responsive CHI with hyperammonaemia (GLUD1), raised 3-hydroxybutyrylcarnitine and/or consanguinity (HADH), positive family history (GCK) or when CHI was diagnosed within the first week of life (HNF4A).
|
23345197 |
2013 |
Congenital Hyperinsulinism
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A.
|
22802087 |
2012 |
Congenital Hyperinsulinism
|
0.200 |
Biomarker
|
disease |
BEFREE |
Unlike HNF4-MODY where fetal macrosomia and early postnatal hyperinsulinemic hypoglycemia have been reported, history of transient insulin overproduction has not yet been recognized in individuals with HNF1A-MODY.
|
21648289 |
2011 |
Congenital Hyperinsulinism
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Hepatocyte nuclear factor 4α gene mutation associated with familial neonatal hyperinsulinism and maturity-onset diabetes of the young.
|
21353246 |
2011 |
Congenital Hyperinsulinism
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Activity and protein expression of GK-MODY and persistent hyperinsulinemic hypoglycemia of infancy (PHHI) mutants were studied in β-cell (MIN6) and non-β-cell (H4IIE) models.
|
22028181 |
2011 |
Congenital Hyperinsulinism
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
HADH mutations are a relatively common cause of diazoxide-responsive HH with a frequency similar to that of GLUD1 and HNF4A mutations.
|
21252247 |
2011 |
Congenital Hyperinsulinism
|
0.200 |
Biomarker
|
disease |
BEFREE |
Unlike HNF4-MODY where fetal macrosomia and early postnatal hyperinsulinemic hypoglycemia have been reported, a history of transient insulin overproduction has not been recognized in individuals with HNF1A-MODY yet.
|
21823540 |
2011 |
Congenital Hyperinsulinism
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Rare forms of congenital hyperinsulinism (CHI) are caused by mutations in GLUD1 (encoding glutamate dehydrogenase), GCK (encoding glucokinase), HADH (encoding for L-3-hydroxyacyl-CoA dehydrogenase), SLC16A1 (encoding the monocarboxylat transporter 1), HNF4A (encoding hepatocyte nuclear factor 4α) or UCP2 (encoding mitochondrial uncoupling protein 2).
|
21186003 |
2011 |
Congenital Hyperinsulinism
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Congenital hyperinsulinism due to mutations in HNF4A and HADH.
|
20931292 |
2010 |
Congenital Hyperinsulinism
|
0.200 |
Biomarker
|
disease |
BEFREE |
We sequenced the ABCC8, KCNJ11, GCK, GLUD1, and/or HNF4A genes in 220 patients with HH responsive to diazoxide.
|
20164212 |
2010 |
Congenital Hyperinsulinism
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Recently, heterozygous mutations in the HNF4A gene were reported to cause transient hyperinsulinemic hypoglycemia associated with macrosomia.
|
18268044 |
2008 |
Congenital Hyperinsulinism
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
HNF4alpha mutations paradoxically also cause in utero and neonatal hyperinsulinism, which later evolves to decreased glucose-induced secretion.
|
17923767 |
2007 |
Congenital Hyperinsulinism
|
0.200 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Congenital Hyperinsulinism
|
0.200 |
Biomarker
|
disease |
HPO |
|
|
|